Alcohol Use Disorder
Alcohol use disorder (AUD) is one of the most common substance use disorders characterized by excessive, uncontrollable drinking that impacts a person physically, emotionally, and socially. It can be mild, moderate, or severe, based on the number of symptoms experienced by an individual. A person with AUD may experience both intoxication and withdrawal symptoms such as unstable moods, poor judgment, slurred speech, problems with attention or memory, poor coordination, sweating, rapid heartbeat, hand tremors, seizures, etc.&nbsp;
&nbsp;
Alcohol Use Disorder Epidemiology Segmentation in the 7MM
&nbsp;
<ul>
<li class="ql-align-justify">12-month Diagnosed Prevalent Cases of AUD</li>
<li class="ql-align-justify">Gender-specific Diagnosed Prevalent Cases of AUD</li>
<li class="ql-align-justify">Type-specific Diagnosed Prevalent Cases of AUD</li>
</ul>
&nbsp;
<a style="color: black;" href="https://www.delveinsight.com/report-store/alcohol-use-disorder-epidemiology-forecast" target="_blank" rel="noopener noreferrer">Alcohol Use Disorder Epidemiological Insights Observed in the 7MM</a> (2021)
The total number of incident cases of Alcohol Use Disorder observed in the 7MM was observed to be 25 million in the year 2021
&nbsp;
<a style="color: black;" href="https://www.delveinsight.com/report-store/alcohol-use-disorder-market" target="_blank" rel="noopener noreferrer">Alcohol Use Disorder Market Insight</a>
The market size of Alcohol Use Disorder in the 7MM was found to be USD 564.0 million in 2021
&nbsp;
Alcohol Use Disorder Market Strengths
The increasing population of cocaine users and increasing episodes of Alcohol Use Disorder worldwide likely cause a surge in treatment options. Consequently, the market will witness a boost in the upcoming year.&nbsp;
&nbsp;
Alcohol Use Disorder Market Opportunities
Various big Pharma key players are currently active in the development of a novel drug for the treatment of MG.
&nbsp;
<a style="color: black;" href="https://www.delveinsight.com/report-store/alcohol-use-disorder-pipeline-insight" target="_blank" rel="noopener noreferrer">Alcohol Use Disorder Emerging Drugs and Key Companies</a>
&nbsp;
<ul>
<li>AD04 (ondansetron): Adial Pharmaceuticals</li>
<li>MN-166 (ibudilast): MediciNova</li>
<li>CORT 118335 (Miricorilant) (mifepristone): Corcept Therapeutics</li>
<li>ASP 8062: Astellas Pharma</li>
<li>BP1.3656: Bioprojet</li>
</ul>

Alcohol Use Disorder Market

Alcohol Use Disorder Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.